ProductNum | picture | CAS No. | Name and description | Formula | Quick order |
---|---|---|---|---|---|
CL2535 |
|
55779-48-1 |
Coelenterazine 98+% |
C26H21N3O3 | |
CLA1360 |
|
1442657-12-6 |
Pasotuxizumab 95+% |
— | |
CLA1356 |
|
1630074-14-4 |
Denintuzumab (Anti-CD19) 95+% |
— | |
CLA1354 |
|
946415-62-9 |
Ontuxizumab (Anti-TEM1 / Endosialin / CD248) 95+% |
— | |
CLA1353 |
|
1269764-99-9 |
Coltuximab (Anti-CD19) 95+% |
— | |
CLA1350 |
|
1418205-77-2 |
Bimekizumab 95+% |
— | |
CLA1345 |
|
1416147-64-2 |
Dapirolizumab pegol 95+% |
— | |
CLA1344 |
|
1357158-22-5 |
Fletikumab (Anti-IL-20) 95+% |
— | |
CLA1341 |
|
1448664-46-7 |
Enfortumab (Anti-Nectin-4) 95+% |
— | |
CLA1340 |
|
1326232-46-5 |
Anifrolumab (Anti-IFNAR1) 95+% |
— | |
CLA1338 |
|
1954758-84-9 |
Anetumab (Anti-Mesothelin) 95+% |
— | |
CLA1335 |
|
1350289-85-8 |
Guselkumab (Anti-IL-23) 95+% |
— | |
CLA1324 |
|
1313706-14-7 |
Pinatuzumab (Anti-Siglec-2 / CD22) 95+% |
— | |
CLA1320 |
|
1036730-42-3 |
Pidilizumab (Anti-PDCD1 / PD-1 / CD279) 95+% |
— | |
CLA1317 |
|
1326244-10-3 |
Tildrakizumab (Anti-IL-23a) 95+% |
— | |
CLA1316 |
|
1190264-60-8 |
Dupilumab (anti-IL-4Rα) 95+% |
— | |
CLA1311 |
|
1331830-76-2 |
Perakizumab (Anti-CTLA-8 / IL-17a) 95+% |
— | |
CLA1308 |
|
1169956-08-4 |
Ocaratuzumab (Anti-CD20) 95+% |
— | |
CLA1305 |
|
1278466-20-8 |
Lampalizumab (Anti-Complement Factor D) 95+% |
— | |
CLA1298 |
|
1236278-28-6 |
Clazakizumab (Anti-IL-6 / IFNb2) 95+% |
— | |